KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $713,000 | +88.6% | 3,967 | +8.7% | 0.00% | +33.3% |
| Q2 2017 | $378,000 | +34.0% | 3,651 | +1.4% | 0.00% | +50.0% |
| Q1 2017 | $282,000 | +16.0% | 3,599 | -17.3% | 0.00% | 0.0% |
| Q3 2016 | $243,000 | -9.3% | 4,352 | -18.9% | 0.00% | 0.0% |
| Q2 2016 | $268,000 | +24.1% | 5,364 | +13.8% | 0.00% | +100.0% |
| Q1 2016 | $216,000 | +29.3% | 4,713 | +73.8% | 0.00% | 0.0% |
| Q4 2015 | $167,000 | -12.6% | 2,711 | -21.0% | 0.00% | -50.0% |
| Q3 2015 | $191,000 | +193.8% | 3,432 | +221.0% | 0.00% | – |
| Q2 2015 | $65,000 | -93.7% | 1,069 | -94.0% | 0.00% | -100.0% |
| Q1 2015 | $1,028,000 | +5947.1% | 17,818 | +6044.1% | 0.01% | – |
| Q4 2014 | $17,000 | – | 290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $108,260,000 | 37.66% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,479,000 | 8.02% |
| RTW INVESTMENTS, LP | 343,503 | $15,770,000 | 5.72% |
| DSAM Partners (London) Ltd | 256,550 | $11,778,000 | 5.26% |
| Silver Rock Financial LLC | 109,199 | $5,013,000 | 5.09% |
| Casdin Capital, LLC | 75,000 | $3,443,000 | 3.95% |
| EcoR1 Capital, LLC | 150,000 | $6,887,000 | 2.41% |
| Vivo Capital, LLC | 193,193 | $8,869,000 | 2.22% |
| BB BIOTECH AG | 750,000 | $34,433,000 | 1.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 494,988 | $22,725,000 | 1.36% |